Employer record · Carlsbad, CA · FY2024–FY2025

Creyon Bio, Inc.

    Certified LCAs
    5
    FY2024–FY2026
    USCIS approvals
    1
    1 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $179k
    certified LCAs

    Jobs not indexed yet

    Does Creyon Bio, Inc. sponsor H-1B visas?

    Yes — by its record, Creyon Bio, Inc. is a small-scale H-1B sponsor: it filed 5 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 1 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Mar 4, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep); the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Creyon Bio, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2420–
    FY2531100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Medical Scientists, Except Epidemiologists 19-10423$179k
    Data Scientists 15-20511$119k
    Molecular and Cellular Biologists 19-10291$67k

    Most-filed job titles

    1. Director Translational Medicine3$179k
    2. Data Scientist Engineer - Biological/Machine Learning1$119k
    3. Research Associate, Cell and Molecular Biology1$67k

    LCAs per title and median wage offered.

    Where the jobs were

    1. California3 LCAs
    2. North Carolina2 LCAs

    We haven't indexed Creyon Bio's jobs yet

    We read jobs straight from employers' own career sites and haven't added Creyon Bio's yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • Creyon Bio, Inc. (LCA)
    • CREYON BIO INC (USCIS)
    • CREYON BIO, INC. (LCA)

    Creyon Bio, Inc. H-1B: questions people ask

    Does Creyon Bio, Inc. sponsor H-1B visas?

    Yes — by its record, Creyon Bio, Inc. is a small-scale H-1B sponsor: it filed 5 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 1 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Mar 4, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Creyon Bio, Inc. still sponsoring H-1B in 2026?

    Creyon Bio, Inc. had 0 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 3 in FY2025. The latest one in our data was decided Mar 4, 2025. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Creyon Bio, Inc. get approved?

    USCIS recorded 1 approvals (1 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Creyon Bio, Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Creyon Bio, Inc.?

    The median wage offered on Creyon Bio, Inc.'s certified LCAs in FY2024–FY2026 was $179k a year. By job title: Director Translational Medicine $179k (3 LCAs), Data Scientist Engineer - Biological/Machine Learning $119k (1 LCAs) and Research Associate, Cell and Molecular Biology $67k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Creyon Bio, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Medical Scientists, Except Epidemiologists (3), Data Scientists (1) and Molecular and Cellular Biologists (1).

    Where are Creyon Bio, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): California (3) and North Carolina (2).

    Is Creyon Bio, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Creyon Bio, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Creyon Bio's yet.